Dexcom Taps Jake Leach as Next CEO
Dexcom has announced that President and COO Jake Leach will become CEO on January 1, 2026, succeeding longtime leader Kevin Sayer. Leach, a 21-year Dexcom
Dexcom has announced that President and COO Jake Leach will become CEO on January 1, 2026, succeeding longtime leader Kevin Sayer. Leach, a 21-year Dexcom
SetPoint Medical has received FDA approval for its neuroimmune modulation system, a first-of-its-kind implantable device that treats rheumatoid arthritis (RA) through daily vagus nerve stimulation.
The funding includes a $40.1M PIPE led by OrbiMed and Marshall Wace, plus $17.9M from warrant exercises. Proceeds will support operations as the company launches
EvoEndo has received expanded FDA clearance for its Model LE gastroscope, now approved for patients of all ages—from neonates to adults. Previously cleared for ages
London-based Sava Technologies has raised $19 million in Series A funding to propel development of its wearable biosensor, a next-gen continuous glucose monitor (CGM). Unlike
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
